Cite
Morabito F, Tripepi G, Martino EA, et al. Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma. Drug Des Devel Ther. 2021;15:2969-2978doi: 10.2147/DDDT.S295215.
Morabito, F., Tripepi, G., Martino, E. A., Vigna, E., Mendicino, F., Morabito, L., Todoerti, K., Al-Janazreh, H., D'Arrigo, G., Canale, F. A., Cutrona, G., Neri, A., Martino, M., & Gentile, M. (2021). Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma. Drug design, development and therapy, 152969-2978. https://doi.org/10.2147/DDDT.S295215
Morabito, Fortunato, et al. "Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma." Drug design, development and therapy vol. 15 (2021): 2969-2978. doi: https://doi.org/10.2147/DDDT.S295215
Morabito F, Tripepi G, Martino EA, Vigna E, Mendicino F, Morabito L, Todoerti K, Al-Janazreh H, D'Arrigo G, Canale FA, Cutrona G, Neri A, Martino M, Gentile M. Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma. Drug Des Devel Ther. 2021 Jul 08;15:2969-2978. doi: 10.2147/DDDT.S295215. eCollection 2021. PMID: 34262262; PMCID: PMC8275138.
Copy
Download .nbib